Site updated at Wednesday, 22 June 2016

Living with Dementia

Cognitive Enhancement

Nicotine Analog Ups Brain Power in Alzheimer’s

An investigational drug targeting nicotinic receptors not only preserved cognitive function in Alzheimer’s disease patients for 6 months, it showed signs of increasing it, a researcher said here.

Patients taking the highest dose of EVP-6124, a selective partial agonist of alpha-7 nicotinic receptors, in the 24-week trial showed a mean increase of 1.6 points… Nicotine Analog Ups Brain Power in Alzheimer’s   

Out of the shadows - Living with dementia

apoe43 - mini-cognitive assessment1 - immune globulin1 - alpha-synuclein diseases1 - alzheimer's-like tau tangles1 - phosphodiester1 - alzheimer's disease biomarkers1 - fischer1 - atypical antipsychotic drugs1 - mini-strokes2 - prostate cancer1 - ad diagnosing1 - ruth sutherland1 - hypertension3 - metabolic syndrome1 - alzheimer's diagnosis2 - chronic traumatic encephalopathy1 - pneumonia1 - immune system1 - behavioural syndrome1 - hearing loss1 - cognitive health3 - declines in memory1 - agnosia3 - mentally weak1 - early alzheimer's3 - alzheimer's dementia2 - head injuries1 - mayo clinic1 - down syndrome2 -